Human Genome Downgraded By: MarketMinute.com Stock News June 05, 2009 at 17:41 PM EDT ThinkEquity downgraded Human Genome Sciences Inc. (Nasdaq: HGSI) sending the stock price down 33 cents to close at $2.82.